Patent Assignment
Reel/Frame 027380/0156
Assignment of Assignor's Interest
Recorded: 2011-12-14
Pages: 3
Assignor
APTUIT, INC.
Executed: 2011-12-06
Assignee
SALIX PHARMACEUTICALS, LTD.
8510 COLONNADE CENTER DRIVE, RALEIGH, NORTH CAROLINA, 27615
Covered Properties
(3)
Formulations of Rifaximin and Uses Thereof
Formulations of Rifaximin and Uses Thereof
Application:
61/363,609 →
Formulations of Rifaximin and Uses Thereof
Application:
61/419,056 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 14, 2011
From: SELBO, JON; TENG, JING
To: APTUIT, INC.
Reel/Frame 027385/0934 →
Assignment of Assignor's Interest
Jan 4, 2013
From: KABIR, MOHAMMED A.; GOLDEN, PAM
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 029565/0922 →
Security Agreement
Jan 2, 2014
From: SALIX PHARMACEUTICALS, LTD.
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 031896/0752 →
Release of Security Interest
Apr 1, 2015
From: JEFFERIES FINANCE LLC
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 035353/0661 →
Security Agreement
Apr 2, 2015
From: GLYCYX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 035364/0396 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →